中文 | English
Return
Total: 24 , 1/3
Show Home Prev Next End page: GO
Author:(Danli LIU)

1.Inhibition of viral myocarditis by Astragaloside through IL-23/IL-17 signaling pathway

Danli LIU ; Haiying LIU ; Shunli GAO

Journal of Clinical Pediatrics 2014;(6):570-573

2.The express of interleukin-17 in viral myocarditis and intervenient studies of astragaloside

Haiying LIU ; Danli LIU ; Shunli GAO

Chongqing Medicine 2014;(19):2449-2451,2454

3.Vaccination of mice with B16 cells expressing the CRT-E2 fusion protein induces anti-tumor immune responses

Jianlin YANG ; Danli LI ; Changbai LIU

Chinese Journal of Immunology 2001;0(10):-

4.Taxane resistance in metastatic breast cancer and novel microtubule-targeting agents

Yuan HUANG ; Danli LIU ; Xiaojia WANG

Journal of International Oncology 2016;43(8):622-624

5.Expression and clinical significance of miR-200a in childhood B-cell acute lymphoblastic leukemia

Shunli GAO ; Lizhong WANG ; Haiying LIU ; Danli LIU

Journal of Clinical Pediatrics 2015;(2):144-146,150

6.Expression and clinical significance of miR-141 in childhood B-cell acute lymphoblastic leukemia

Shunli GAO ; Lizhong WANG ; Haiying LIU ; Danli LIU

China Oncology 2014;(3):166-169

7.miR-200a inhibits cell proliferation by targeting AP-2γexpression in neuroblastoma cells SK-N-AS

Shunli GAO ; Lizhong WANG ; Haiying LIU ; Danli LIU

Tianjin Medical Journal 2016;44(2):162-165

8.Expression and functional analysis of CRT-E2-EGFP fusion protein in B16 cells

Jianlin YANG ; Changbai LIU ; Danli LI ; Li HAN

Journal of Cellular and Molecular Immunology 2009;25(10):897-899

9.Literature Analysis of ADR Induced by Dasatinib

Jianhong ZHANG ; Ziyan LIU ; Hongna HUANG ; Danli TIAN ; Liqin ZHU

China Pharmacy 2017;28(11):1493-1495

10.Clinical analysis of reoperation on 47 cases of recurrent pelvic endometriosis

Xiuqing HAN ; Lijun LIU ; Jingyao WANG ; Guirong LI ; Danli GAO

Clinical Medicine of China 2012;28(6):666-668

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 24 , 1/3 Show Home Prev Next End page: GO